Horbach, Sophie E R <br/><br/>
Oral sildenafil as a treatment option for lymphatic malformations in PIK3CA-related tissue overgrowth syndromes.  [electronic resource] 

 -  Dermatologic therapy  Nov 2016 
 - 466-469 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1529-8019 
<br/><br/><label>Standard No.: </label>10.1111/dth.12398  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Capillaries--abnormalities<br/>Class I Phosphatidylinositol 3-Kinases<br/>Genetic Predisposition to Disease<br/>Humans<br/>Lymphatic Abnormalities--diagnosis<br/>Male<br/>Mutation<br/>Phenotype<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Sildenafil Citrate--administration & dosage<br/>Syndrome<br/>Treatment Outcome<br/>Vascular Malformations--diagnosis